In this episode, UROONCO BCa chief editor Dr. Benjamin Pradere interviews Assoc. Prof. Yige Bao about his ESMO26 presentation of the Phase II WUTSUP-02 trial results. The WUTSUP-02 trial (ChiCTR2300067836) is a prospective, multi-centre, phase II study evaluating perioperative tislelizumab plus disitamab vedotin for upper tract urothelial carcinoma (UTUC).
They discuss...